Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Ocular and Stem Cell Translational Research Section,
National Eye Institute,
Ocular and Stem Cell Translational Research Section, National Eye Institute
Davide Ortolan has not added Biography.
If you are Davide Ortolan and would like to personalize this page please email our Author Liaison for assistance.
Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model.
Nature communications Dec, 2021 | Pubmed ID: 34911940
Triphasic developmentally guided protocol to generate retinal pigment epithelium from induced pluripotent stem cells.
STAR protocols Sep, 2022 | Pubmed ID: 35880133
Considerations for Developing an Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) Replacement Therapy.
Cold Spring Harbor perspectives in medicine Jul, 2023 | Pubmed ID: 37487631
National Institutes of Health (NIH)
Davide Ortolan1,
Andrei Volkov1,
Arvydas Maminishkis1,
Ruchi Sharma1,
Kapil Bharti1
1Ocular and Stem Cell Translational Research Section, National Eye Institute, National Institutes of Health (NIH)
Zander Esh*,1,
Sharanya Suresh*,1,
Mitra Farnoodian1,
Devika Bose1,
Jiwon Ryu1,
Kapil Bharti1,
Ruchi Sharma1
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved